You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Hungary

Jul 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Hungary with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Hungary, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Hungary for free:

The Consumer Health in Hungary market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Hungary?
  • What are the major brands in Hungary?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health continues to grow

Consumer health value sales continued to increase in 2010 even though sales declined in constant terms. The increase in current sales was due to the strengthening self-medication trend, with a growing number of Hungarians treating themselves for minor health problems instead of visiting a doctor. Stable growth was supported by the strong availability and wide selection of products and rising consumer health consciousness drove sales within certain areas such as dietary supplements.

Moderate allergy and flu season effects sales negatively

The fact that both the allergy and flu seasons were moderate had a negative impact on consumer health sales in 2010. Following remarkable sales growth within analgesics, cough, cold and allergy remedies and vitamins in 2009, 2010 brought only slight growth in current value sales and a decline in constant terms. As most families stocked up on analgesics, cough and cold remedies and vitamins in 2009 due to worries about the H1N1 epidemic, in 2010 many did not need to buy new products.

Multinationals dominate market

There were no significant changes in 2010 regarding the competitive environment within consumer health in Hungary. Large pharmaceutical companies continued to dominate sales due to their leading role in the largest areas, namely analgesics, cough, cold and allergy remedies and digestive remedies. Leading international companies invested large sums in advertising in order to strengthen their market position and also continued to invest in product development. Leading domestic pharmaceutical companies also followed this strategy while smaller players focused on niche segments.

Pharmacies lead sales but are losing distribution share

Chemists and pharmacies preserved their leading role regarding consumer health distribution thanks to the high level of confidence that Hungarians have in such outlets. However, recent trends indicate that other distribution channels are slightly strengthening at the expense of chemists and pharmacies. Drugstores that started to trade OTC medicines following market liberalisation in 2007 were moderately successful and are restructuring product selection, offering less OTC medicines and more vitamins and dietary supplements. Vitamins and dietary supplements are available on retail shelves without any restrictions and consumers usually do not require professional advice to choose them. Therefore, drugstores as well as large grocery outlets significantly widened their assortment of vitamins and dietary supplements, often with their own private label brands. The role of non-store retailing increased with regard to consumer health distribution due to increasing sales via online stores and direct selling.

Growth likely to remain stable

Consumer health is likely to report stable growth over the forecast period. OTC areas that were less affected by the economic crisis will record marginal growth or even a decline in constant terms. Vitamins and dietary supplements, which are considered to be non-essential healthcare products, will probably gain from economic development and increasing household incomes. However, economic indicators of the future performance of the Hungarian economy are highly uncertain at the time of writing.

Table of Contents

Table of Contents

Consumer Health in Hungary - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues to grow

Moderate allergy and flu season effects sales negatively

Multinationals dominate market

Pharmacies lead sales but are losing distribution share

Growth likely to remain stable

KEY TRENDS AND DEVELOPMENTS

Consumer health records stable growth

Economic changes positively affect consumer health

Changing distribution regulations

Medicine security comes to the fore

Promotional activities key to success

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Hungary - Company Profiles

Béres Rt in Consumer Health (Hungary)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Béres Gyógyszergyár Zrt: Competitive Position 2010

Bioextra Kft in Consumer Health (Hungary)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Bioextra Zrt: Competitive Position 2010

Egis Rt in Consumer Health (Hungary)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 EGIS Gyógyszergyár Nyrt: Competitive Position 2010

Gedeon Richter Ltd in Consumer Health (Hungary)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Gedeon Richter Nyrt: Competitive Position 2010

Naturland Magyarország Kft in Consumer Health (Hungary)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 17 Naturland Kft: Competitive Position 2010

Adult Mouth Care in Hungary - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care remains a relatively small consumer health area due to the limited importance of oral hygiene in Hungary. The decline in sales was due to falling household incomes as Hungarian consumers reduced expenditure on non-essential items during the economic crisis. Most Hungarians are not aware of the importance of oral health prevention and usually only visit the dentist when suffering from tooth pain. Nevertheless, attitudes are slowly changing due to the impact of advertising and public campaigns.

SWITCHES

COMPETITIVE LANDSCAPE

  • CSC Pharmaceuticals Handels led sales in 2010, accounting for 40% of retail value sales. The company maintained its leading position due to the popularity of its mouthwash Tantum Verde which is available in both spray and pastille formats and is the most advertised product within adult mouth care. Extractum-Pharma ranked second in 2010, with the company’s Mundisal gel brand recording a retail value share of 25%. GlaxoSmithKline ranked third with a retail value share of 20% thanks to the popularity of its well-known Corsodyl and Chlorhexamed brands.

PROSPECTS

  • Adult mouth care has a projected forecast period constant retail value CAGR of 1%. Value growth will be strongly affected by household incomes which are likely to increase over the coming years. In addition, strengthening health trends will draw people’s attention to the importance of oral hygiene – a development that will help to drive demand for adult mouth care products. However, growth will be limited by the limited advertising activity of producers.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Hungary - Category Analysis

HEADLINES

TRENDS

  • Analgesics current retail value sales increased by a stable 2% in 2010. Sales of analgesics were not significantly affected by the H1N1 flu epidemic in 2010 as the epidemic of the 2009/2010 season culminated at the end of 2009 and the next epidemic only started in the first weeks of 2011. Manufacturers did not concentrate on new product development and instead invested large sums in advertising which has been proven to be highly effective at attracting Hungarian consumers. The most important event during a relatively quiet year was the re-switching of topical analgesics products containing ketoprofen. The decision significantly influenced brand shares in the area as leading brands, namely Fastum gel and Keplat patches, have only been available via prescription since September 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Aventis maintained its leading position within analgesics in 2010, accounting for 23% of retail value sales. The company’s Algoflex brand, which contains the active ingredient ibuprofen, is the leading systemic analgesics brand in the country whilst its Rubophen brand leads sales within acetaminophen. Bayer ranked second in 2010 with a retail vale share of 16% due to its wide selection of brands containing aspirin. Bayer offers Aspirin Plus C and Aspirin Komplex in addition to the traditional Aspirin brand that is available in different strengths. Wyeth Whitehall Hungary ranked third within analgesics with a retail value share of 7% due to its widely advertised Advil brand which is the second best-selling product within ibuprofen and the third most popular product within analgesics as a whole.

PROSPECTS

  • Analgesics has a projected forecast period constant retail value CAGR of 1%, with sales expected to reach 15.5 billion by 2015. As the H1N1 flu epidemic is considered to be not as threatening as people thought, worries about the epidemic will not generate extra demand for analgesics. However, the timing and severity of the flu season will continue to affect sales of analgesics over the coming years.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Hungary - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping was one the best performing consumer health areas in 2010, with current retail value sales increasing by 7%. Demand within the area was fuelled by the increasingly hectic pace of modern life in Hungary and the negative impact of the economic crisis on consumer stress levels. More and more people live alone, bear more stress in the workplace and are suffering from anxiety, depression, or insomnia. Before visiting the doctor, many consumers are willing to try mild OTC treatments.

SWITCHES

COMPETITIVE LANDSCAPE

  • Teva Magyarország led calming and sleeping sales in 2010, recording a retail value share of 35% due to the popularity of its Valeriana brand. Valeriana is the most popular calming and sleeping product and another product from a different manufacturer is available under the same brand name. Gebro Broschek ranked second in 2010 with a retail value share of 28% thanks to its Hova brand. Dr Willmar Schwabe ranked third, accounting for 24% of retail value sales due to the popularity of its Euvekan brand. There were no significant changes in company value shares in 2010 since the year was relatively eventless with regard to both product development and advertising.

PROSPECTS

  • Calming and sleeping is expected to record slight but stable value sales growth over the forecast period. The area has a projected forecast period constant retail value CAGR of 1%. Although new products are not likely to be launched, Hungarians will be loyal to well-known brands such as Valeriana when suffering from minor health problems. Nevertheless, in the case of more serious symptoms, most people will look to visit their doctor and ask for stronger prescription-only products.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Hungary - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy remedies current retail value sales increased by 2% in 2010 while constant sales decreased by 2%. The H1N1 epidemic fuelled significant sales growth in 2009. However, the fact that there was no significant flu epidemic in 2010 had a negative impact on sales, with value growth only occurring due to price rises.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis led cough, cold and allergy remedies sales in 2010, accounting for 20% of retail value sales. The company manufactures Neo Citran, the best-selling combination remedy and leading cough, cold and allergy product in Hungary. Novartis is also present within decongestants with its Vibrocil and Otrivin brands and its Mebucain brand is the second leading product within pharyngeal preparations. Gyori Keksz ranked second in 2010 with a retail value share of 9% due to its traditionally popular Negro brand which helps to relieve sore throats. As Negro is also a sweet, Gyori Keksz benefits from the fact that the brand is available in all types of grocery outlets in addition to drugstores and pharmacies. GlaxoSmithKline ranked third in 2010, recording a retail value share of 7%. The company is benefiting from the increasing popularity of combination products and rising demand for its Coldrex brand.

PROSPECTS

  • Cough, cold and allergy remedies value sales are expected to stagnate in constant terms during the forecast period. The area has reached maturity and only limited new product launches are expected over the coming years. New product launches will instead result in a change in brand market shares but not a significant increase in overall demand. Sales will be affected both by the flu season and the popularity of flu vaccinations. However, allergy remedies are expected to develop further due to former switches and the fact that an increasing number of Hungarians are suffering from allergies.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Hungary - Category Analysis

HEADLINES

TRENDS

  • In 2009, Nycomed obtained permission to launch the first proton pump inhibitor product in Europe. In Hungary, the first such product to be launched was Controloc Control, which has been available since the end of 2009. In 2010, Nycomed’s other brand, Pantoloc Control, was launched and was followed by a couple of other brands that contain 20mg of pantoprazole. By the end of 2010, the National Institute of Pharmacy had registered six products in the area. Proton pump inhibitors offer efficient relief for people who suffer from reflux.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer led sales within digestive remedies in 2010, accounting for 13% of retail value sales. Bayer manufactures Rennie, the best-selling digestive remedies brand, and operates within a number of different areas. Berlin-Chemie Budapest ranked second in 2010, recording a retail value share of 12% due to the popularity of its antiflatulent brand Espumisan. Sanofi-Aventis offers its No-spa brand, which is primarily recommended for the treatment of IBS, and ranked third within the area in 2010 with a retail value share of 10%. Domestic companies Egis and Gedeon Richter were also successful in 2010, accounting for 9% and 7% of retail value sales respectively.

PROSPECTS

  • Value sales of digestive remedies are projected to stagnate in constant terms over the forecast period. Strengthening health-prevention trends and the increasing importance of healthy eating habits will negatively affect sales since a growing number of Hungarians are suffering from digestive problems caused by unhealthy eating. However, accelerated life styles and the stress of everyday life are expected to result in an increase in the number of Hungarians suffering from digestive problems. In addition, intensive manufacturer advertising activity will also support digestive remedy sales. These positive and negative effects are expected to cancel one another out over the forecast period.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Hungary - Category Analysis

HEADLINES

TRENDS

  • Ear care current retail value sales increased slightly in 2010 due to unit price rises. Ear care constant retail value sales continue to decline as the area is one of the most underdeveloped consumer health areas in Hungary due to the fact that most ear care products are available only with a prescription and that Hungarian consumers typically prefer to go to the doctor when suffering from ear problems rather than treating them themselves with OTC products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Teva Magyarország led ear care sales in 2010, recording a retail value share of 86%. Teva’s Otipax brand is the only ear drop product that is available without prescription and is offered for minor pains and inflammation. Laboratoires Diepharmex ranked second in 2010, recording a retail value share of 10% due to the popularity of its well-known ear cleaning spray, Audispray. The brand has been frequently advertised on TV and in magazines since its launch. However, doctors do not recommend it to patients.

PROSPECTS

  • Ear care is likely to remain a small consumer health area over the forecast period. As self-medication in the area is not typical, people will continue to visit their doctor and ask for professional advice in most cases. Ear cleaning sprays are an example of innovation within the area. However, the fact that their use is not recommended by doctors continues to limit demand. As a result, ear care has a projected forecast period constant retail value CAGR of -3%.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Hungary - Category Analysis

HEADLINES

TRENDS

  • Eye care current retail value sales continued to increase in 2010 due to the fact that a growing number of people are suffering from allergy symptoms and are using computers in everyday life. Eye care is a relatively small consumer health area in Hungary, accounting for just 1% of overall current retail value sales in 2010. However, this value share has been increasing in recent years as more and more people use computers and suffer from red eye and dry eye symptoms. Allergies are also affecting an increasing number of Hungarians, who often try OTC eye care products when suffering from mild symptoms.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pfizer led eye care sales in 2010, accounting for 48% of retail value sales. Pfizer’s Visine is the best-selling eye care brand in Hungary and comes in five variants for tired, dry and sensitive eyes. Alcon ranked second in 2010 with a retail value share of 27% thanks to the popularity of its Tears Naturale brand. In addition, Alcon also offers its Dacrolux eye drops brand which is designed to treat dry eye symptoms. Teva Magyarország ranked third in 2010 with a retail value share of 11%. The company is the third leading player within both standard and allergy eye care due to the popularity of its Humalac and Opticrom brands.

PROSPECTS

  • Eye care constant retail value sales are projected to increase by a total of 9% over the forecast period. Demand will be driven by increasing air pollution, the fact that a growing number of people are spending long hours in front of computer screens, and severe allergy seasons during spring and summer.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2005-2010
  • Table 54 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 55 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 56 Eye Care Company Shares by Value 2006-2010
  • Table 57 Eye Care Brand Shares by Value 2007-2010
  • Table 58 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Hungary - Category Analysis

HEADLINES

TRENDS

  • Herbal and traditional products continue to benefit from the increasing popularity of herbal remedies in Hungary. Many people who are wary of the side-effects of medicines often turn to herbal products since they are considered to be safer and gentler. Growth is also being fuelled by the widening range of available products and improving distribution, with more and more retail outlets offering more shelf space for herbal products.

COMPETITIVE LANDSCAPE

  • Gyori Keksz led herbal and traditional products sales in 2010, recording a retail value share of 10%. The company’s Negro brand leads sales within medicated confectionery and is available in a number of different flavours. Negro products are sold through all important distribution channels, especially grocery outlets. Forever Living Products ranked second in 2010, recording a retail value share of 8% due to the popularity of its Forever Living dietary supplements. Berlin-Chemie ranked third and also recorded a retail value share of 8% thanks to its Prostamol Uno brand which is designed to treat urea problems and has become highly popular amongst male consumers.

PROSPECTS

  • Herbal and traditional products will continue to record value sales growth over the forecast period, with constant sales projected to increase at an average annual rate of 1%. The strengthening health trend is likely to drive value sales growth since Hungarians will tend to take more care of their health and will be willing to spend more on preventative medicines. In response to the increasing popularity of herbal products, manufacturers will look to invest in new product development and launch new products with herbal ingredients.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 62 Herbal/Traditional Products Company Shares 2006-2010
  • Table 63 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Hungary - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care continues to be negatively impacted by the economic crisis and the fact that many Hungarian consumers are spending less on non-essential products. In addition, increasing competition amongst frequently advertised cosmetics brands also limited growth within the area. As a result, constant value sales continued to decrease in 2010. However, current retail value growth was positive due to the impact of significant price increases. The decline in constant retail value sales in 2010 was slower than that of recent years. Although household incomes still decreased in 2010, constant retail value sales declined by -2%.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer led medicated skin care sales in 2010, recording a retail value share of 16%. Bayer’s Canesten brand, which comes in a number of different variations, is the best-selling topical antifungals product and also the leading medicated skin care brand overall. Canesten is available in different formats and Hungarians are loyal to this tried and tested and high quality brand. Janssen-Cilag ranked second in 2010 due to the popularity of its Pevaryl and Nizoral brands, which recorded a combined retail value share of 11% and led sales within vaginal antifungals and medicated shampoos respectively. Novartis was the third leading player in 2010, accounting for 8% of retail value sales. The company’s most popular brand, Fenistil, is the best-selling brand within topical allergy remedies and can be found in the majority of Hungarian households.

PROSPECTS

  • Value sales of medicated skin care products are likely to stagnate in constant terms over the forecast period. The fact that medicated skin care products will face increased competition from cosmetics will limit growth over the coming years. In addition, general economic conditions and household income levels will also influence growth. For example, the fact that Hungarians are unlikely to experience a rapid increase in incomes over the forecast period will negatively affect medicated skin care growth.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 68 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 69 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 70 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 71 Acne Treatments Brand Shares by Value 2007-2010
  • Table 72 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 73 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 74 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Sports Nutrition in Hungary - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition products developed rapidly in 2010 due to the strengthening health and wellness trend. Being muscular and good-looking is becoming increasingly important for younger male consumers and more and more young men are engaging in body building and fitness and using sports nutrition products in order to achieve their goals as fast as possible. In response to this trend, manufacturers are investing large sums in developing distribution and opening new outlets.

COMPETITIVE LANDSCAPE

  • BioTech Nutrition led sales in 2010, recording a retail value share of 35% due to the popularity of its Biotech brand. The company continues to attract new consumers with new product launches and effective communication.

PROSPECTS

  • Sports nutrition value sales will continue to increase over the forecast period due to the increasing popularity of body building and sport amongst Hungarian consumers. Constant retail value sales are projected to increase at an average annual rate of 2% over the forecast period due to the increasing availability of products and rising consumer health awareness. Value sales growth is likely to be influenced by rising household incomes over the coming years.

CATEGORY DATA

  • Table 75 Sports Nutrition, category rankings 2010
  • Table 76 Sales of Sports Nutrition: Value 2005-2010
  • Table 77 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 78 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 79 Sports Nutrition Company Shares 2006-2010
  • Table 80 Sports Nutrition Brand Shares 2007-2010
  • Table 81 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 82 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Hungary - Category Analysis

HEADLINES

TRENDS

  • The flu epidemic affected sales of vitamins and dietary supplements positively in 2009. In 2010, worries over the H1N1 epidemic weakened. However, sales still increased in both current and constant terms. Vitamins and dietary supplements are becoming increasingly popular in Hungary due to the strengthening health-prevention trend and the wide selection of products on offer. Although most Hungarians continued to face financial problems in 2010, they were willing to spend on preventative medicines.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Béres maintained its leading position within vitamins and dietary supplements in 2010, recording a retail value share of 15%. Béres is one of the most reliable domestic brands in Hungary and enjoys an excellent reputation. The company’s Béres Drops is the best-selling product within consumer health in Hungary and offers a mixture of minerals to help maintain health. Béres is present within most vitamins and dietary supplements areas, especially non-herbal dietary supplements, and its most popular products are Actival and Actival Kid (multivitamins) and Béres Drops. Teva Magyarország was the second leading company within vitamins and dietary supplements in 2010, recording a retail value share of 7%. The company was the leading innovator within the area in 2010, launching a new dietary supplements product range. The success of Teva Magyarország can mainly be attributed to the popularity of its Eurovit single and multivitamins brands. Sanofi-Aventis ranked third in 2010, recording a retail value share of 7%. Magne B6, the company’s most popular dietary supplement, ranked second within mineral supplements whilst its Normaflore brand led sales within probiotic supplements

PROSPECTS

  • Vitamins and dietary supplements has a projected forecast period constant retail value CAGR of 1%. Although vitamins and dietary supplements has reached a high level of maturity, the number of products on offer will increase further over the forecast period. As Hungarians are taking more care of their health, demand for preventative products is likely to increase. Leading manufacturers will look to maintain consumer interest with intensive advertising over the coming years.

CATEGORY DATA

  • Table 83 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 84 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 85 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 86 Dietary Supplements by Positioning 2005-2010
  • Table 87 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 88 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 89 Vitamins Brand Shares by Value 2007-2010
  • Table 90 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 91 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 92 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Hungary - Category Analysis

HEADLINES

TRENDS

  • Weight management was one of the worst performing areas within consumer health in 2010, with current retail value and constant retail value sales declining by 1% and 5% respectively. Although unhealthy eating habits and the high rate of overweight people are crucial problems in Hungary, solving these problems was forced to the background given the difficult economic circumstances of recent years. Peoples’ worries about their standard of living and incomes prevented them from starting diet programmes or spending on expensive slimming products.

COMPETITIVE LANDSCAPE

  • Bio-Fit led weight management sales in 2010, recording a retail value share of 9% due to the popularity of its well-known Metabol brand. Pharma Nord was the second best-performing company, accounting for 7% of retail value sales due to the popularity of its Bio-Cla, Bio-Cla+T, Bio Króm and Bio Slim weight loss supplements. Forever Living Products ranked third, with the company leading sales within meal replacement slimming. GlaxoSmithKline was fourth, recording a retail value share of 7% due to the success of its OTC obesity brand, Alli.

PROSPECTS

  • Weight management value sales will decrease marginally from 2010 to 2015 in current terms. The decline in constant sales is likely to end in 2013, with steady growth projected from 2014 onwards. Considering the high number of overweight people and rising consumer health awareness, the area has great potential to grow over the forecast period. However, future sales will be limited by difficult economic circumstances.

CATEGORY DATA

  • Table 93 Sales of Weight Management: Value 2005-2010
  • Table 94 Sales of Weight Management: % Value Growth 2005-2010
  • Table 95 Weight Management Company Shares 2006-2010
  • Table 96 Weight Management Brand Shares 2007-2010
  • Table 97 Forecast Sales of Weight Management: Value 2010-2015
  • Table 98 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Hungary - Category Analysis

HEADLINES

TRENDS

  • Wound care current retail value sales increased in 2010 due to rising unit prices while constant sales continued to decrease. Although leading brands like Hansaplast and Salvequick are well-known in Hungary, cheap and low quality brands entered the area in recent years and have proven popular amongst price sensitive consumers.

COMPETITIVE LANDSCAPE

  • Hartmann-Rico led sales in 2010, accounting for 26% of wound care retail value sales. Hartmann-Rico led sales within gauze, tape and other wound care – the largest wound care areas. Nagév Kötszer ranked second with a retail value share of 21%. The company’s Pharmico brand competes within the lower price segment and is popular amongst price-sensitive Hungarians. Cederroth ranked third within wound care with a retail value share of 13% due to its best-selling sticking plaster brand Salvequick. Beiersdorf remained an important player in the area, accounting for 12% of retail value sales due to the popularity of its Hansaplast and Leukoplast brands.

PROSPECTS

  • Wound care value sales are projected to decline at an average annual rate of 1% over the forecast period. Wound care has reached maturity and the latest innovations within the area mainly involve the packaging and decoration of products and are unlikely to significantly boost growth. Decreasing and stagnating household incomes will also limit growth over the coming years as most Hungarians will continue to purchase cheaper private label brands at the expense of less well-known and more expensive brands. However, leading brands will be able to maintain their positions due to their high quality and strong promotional support.

CATEGORY DATA

  • Table 99 Sales of Wound Care by Category: Value 2005-2010
  • Table 100 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 101 Wound Care Company Shares by Value 2006-2010
  • Table 102 Wound Care Brand Shares by Value 2007-2010
  • Table 103 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 104 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Green Tea Extract
            • Isoflavones
            • Pumpkin Seed
            • Saw Palmetto
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report